Every story and comment from the Hacker News API, in a layout borrowed from 2001.
A comment on 23andMe has signed a $300M deal with GlaxoSmithKline. Parent comment
Ancestry is not 23andme’s owner. They are competitors.
There are no comments on this comment yet.
Ancestry is not 23andme’s owner. They are competitors.